loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

List of Drug Master Files (JDMF) for DSSTox_CID_28933 Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Japan (PMDA). Original Data : PMDA Database

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Nippon Rikagaku Yakuhin Co., Ltd. (2)

02 Permakem Asia Co., Ltd. (1)

03 Sanyo Chemical Research Institute Co., Ltd. (1)

filter

01 Ibudilast (2)

02 Japanese Pharmacopoeia ibudilast (1)

03 Outsider regulations ibudilast (1)

filter

01 Gabon (1)

02 Japan (3)

URL Supplier Web Content
219MF10339
4-2-2 Nihonbashi Honmachi, Chuo-ku,...
2007-11-21
2007-11-21
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
217MF10064
4-2-2 Nihonbashi Honmachi, Chuo-ku,...
2006-03-09
2005-05-20
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
217MF10715
1-10-11 Nihonbashi Horidome-cho, Ch...
2008-12-22
2005-10-07
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Sanyo Chemical Research Institute C...

Contact Supplier
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
221MF10139
148-1 Tajii, Mihara Ward, Sakai Cit...
2009-07-09
2009-07-09
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 50847-11-5 / Ibudilast API manufacturers, exporters & distributors?

Ibudilast manufacturers, exporters & distributors 1

49

PharmaCompass offers a list of Ibudilast API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ibudilast manufacturer or Ibudilast supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ibudilast manufacturer or Ibudilast supplier.

PharmaCompass also assists you with knowing the Ibudilast API Price utilized in the formulation of products. Ibudilast API Price is not always fixed or binding as the Ibudilast Price is obtained through a variety of data sources. The Ibudilast Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Ibudilast

Synonyms

50847-11-5, Ketas, Kc-404, Mn-166, Ibudilastum, Ke tas

Cas Number

50847-11-5

Unique Ingredient Identifier (UNII)

M0TTH61XC5

About Ibudilast

Ibudilast is an orally bioavailable inhibitor of cyclic nucleotide phosphodiesterase (PDE), mainly PDE-3, -4, -10, and -11, with anti-(neuro)inflammatory, vasorelaxant, bronchodilator, analgesic, neuroprotective and potential anti-tumor activities. Ibudilast (IBD) is able to cross the blood-brain barrier (BBB). Upon administration, IBD exerts its potential anti-tumor activity against glioblastoma multiforme (GBM) cells by inhibiting PDE-4 and the pro-inflammatory cytokine macrophage migration inhibitory factor (MIF), which results in a decrease in MIF, its receptor CD74, and AKT expression, and attenuates the immunosuppressive properties of monocytic myeloid-derived suppressor cells (MDSCs) and reduces T-regulatory cells (Tregs). This causes GBM cell apoptosis and inhibits GBM cell proliferation. In addition, IBD reduces, through its inhibitory effect on various PDEs, the production of certain pro-inflammatory cytokines, such as interleukin-6 (IL-6), IL- 1beta, leukotriene B4, and tumor necrosis factor-alpha (TNF-a). IBD also upregulates the anti-inflammatory cytokine (IL-10), and promotes the production of neurotrophic factors, such as brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and neurotrophin-4 (NT-4). It also blocks toll-like receptor-4 (TLR-4), inhibits nitric oxide (NO) synthesis and reduces the level of reactive oxygen species (ROS). It also prevents platelet aggregation, causes cerebral vasodilation, bronchial smooth muscle relaxation, and improves cerebral blood flow. In addition, IBD attenuates the PDE-mediated activation of glial cells and abrogates PDE-mediated neuroinflammation and neurodegeneration. MIF is secreted by cancer stem cells (CSCs) and is highly expressed within GBM and plays a key role in tumor cell proliferation. Co-expression of MIF and CD74 in GBM is associated with poor patient survival.

DSSTox_CID_28933 Manufacturers

A DSSTox_CID_28933 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_CID_28933, including repackagers and relabelers. The FDA regulates DSSTox_CID_28933 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_CID_28933 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of DSSTox_CID_28933 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

DSSTox_CID_28933 Suppliers

A DSSTox_CID_28933 supplier is an individual or a company that provides DSSTox_CID_28933 active pharmaceutical ingredient (API) or DSSTox_CID_28933 finished formulations upon request. The DSSTox_CID_28933 suppliers may include DSSTox_CID_28933 API manufacturers, exporters, distributors and traders.

click here to find a list of DSSTox_CID_28933 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

DSSTox_CID_28933 JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The DSSTox_CID_28933 Drug Master File in Japan (DSSTox_CID_28933 JDMF) empowers DSSTox_CID_28933 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the DSSTox_CID_28933 JDMF during the approval evaluation for pharmaceutical products. At the time of DSSTox_CID_28933 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of DSSTox_CID_28933 suppliers with JDMF on PharmaCompass.

DSSTox_CID_28933 Manufacturers | Traders | Suppliers

DSSTox_CID_28933 Manufacturers, Traders, Suppliers 1
34

We have 2 companies offering DSSTox_CID_28933

Get in contact with the supplier of your choice:

  1. Nihon Rikagaku
  2. Permachem Asia, Ltd
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY